REGENERON PHARMACEUTICALS, INC. Weighted Avg Shares (Basic) 2010-2026 | REGN
What is weighted avg shares (basic)?
Weighted average shares outstanding (basic) is the time-weighted average number of common shares outstanding during the reporting period, used as the denominator to calculate basic earnings per share.
What is REGENERON PHARMACEUTICALS, INC.'s current weighted avg shares (basic)?
REGENERON PHARMACEUTICALS, INC. (REGN) annual weighted avg shares (basic) for 2025 was 104.6M, a 3.06% decline from 2024. REGENERON PHARMACEUTICALS, INC. weighted avg shares (basic) for the quarter ending March 31, 2026 was 104.0M.
What was REGENERON PHARMACEUTICALS, INC.'s weighted avg shares (basic) in 2024?
REGENERON PHARMACEUTICALS, INC. annual weighted avg shares (basic) for 2024 was 107.9M, a 1.12% increase from 2023.
What was REGENERON PHARMACEUTICALS, INC.'s weighted avg shares (basic) in 2023?
REGENERON PHARMACEUTICALS, INC. annual weighted avg shares (basic) for 2023 was 106.7M, a 0.37% decline from 2022.
What is REGENERON PHARMACEUTICALS, INC.'s 5-year weighted avg shares (basic) CAGR?
REGENERON PHARMACEUTICALS, INC. weighted avg shares (basic) grew at a compound annual growth rate (CAGR) of 0.56% from FY2020 to FY2025, going from 107.6M to 104.6M over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | 104.6M | -3.1% | 10-K |
| FY2024 | 107.9M | +1.1% | 10-K |
| FY2023 | 106.7M | -0.4% | 10-K |
| FY2022 | 107.1M | +1.3% | 10-K |
| FY2021 | 105.7M | -1.8% | 10-K |
| FY2020 | 107.6M | -1.5% | 10-K |
| FY2019 | 109.2M | +1.2% | 10-K |
| FY2018 | 107.9M | +1.5% | 10-K |
| FY2017 | 106.3M | +1.5% | 10-K |
| FY2016 | 104.7M | +1.6% | 10-K |
| FY2015 | 103.1M | +2.4% | 10-K |
| FY2014 | 100.6M | +2.8% | 10-K |
| FY2013 | 97.9M | +3.4% | 10-K |
| FY2012 | 94.7M | +4.5% | 10-K |
| FY2011 | 90.6M | +9.3% | 10-K |
| FY2010 | 82.9M | - | 10-K |